Pulmonary Medicine (Jan 2011)

Perfluorochemical Liquid-Adenovirus Suspensions Enhance Gene Delivery to the Distal Lung

  • Jeffrey A. Kazzaz,
  • Marlene S. Strayer,
  • Jichuan Wu,
  • Daniel J. Malone,
  • Hshi-chi Koo,
  • Thomas H. Shaffer,
  • Jonathan M. Davis,
  • David S. Strayer,
  • Marla R. Wolfson

DOI
https://doi.org/10.1155/2011/918036
Journal volume & issue
Vol. 2011

Abstract

Read online

We compared lung delivery methods of recombinant adenovirus (rAd): (1) rAd suspended in saline, (2) rAd suspended in saline followed by a pulse-chase of a perfluorochemical (PFC) liquid mixture, and (3) a PFC-rAd suspension. Cell uptake, distribution, and temporal expression of rAd were examined using A549 cells, a murine model using luciferase bioluminescence, and histological analyses. Relative to saline, a 4X increase in transduction efficiency was observed in A549 cells exposed to PFC-rAd for 2–4 h. rAd transgene expression was improved in alveolar epithelial cells, and the level and distribution of luciferase expression when delivered in PFC-rAd suspensions consistently peaked at 24 h. These results demonstrate that PFC-rAd suspensions improve distribution and enhance rAd-mediated gene expression which has important implications in improving lung function by gene therapy.